J Korean Assoc Maxillofac Plast Reconstr Surg.  2009 Sep;31(5):414-418.

Oral Pemphigus Vulgaris: A Case Report

Affiliations
  • 1Department of Oral and Maxillofacial Surgery, Department of Dentistry, College of Medicine, In-Ha University, Incheon, Korea. kik@inha.ac.kr
  • 2Department of Pathology, College of Medicine, In-Ha University, Incheon, Korea.

Abstract

Pemphigus vulgaris is a chronic autoimmune intraepithelial blistering disease with oral mucosal manifestations that very often precede the skin lesions. The vesicles or bullae are produced by an acantholytic process, detachment of differentiating keratinocytes from one another in the epithelial stratum spinosum or spinous cell layer. The pathogenesis of this disease is initially manifested by IgG(mainly) binding to desmosome(desmoglein 3 or 1) in the intercellular spaces of epithelium. This autoantibody binding caused the release of a plasminogen activator(a proteolytic enzyme) from keratinocytes. This ultimately results in cell to cell separation. The mainstay therapy of pemphigus vulgaris is systemic corticosteroids and immunosuppressive agents to eliminate the pathogenic autoantibodies from circulation. A 41-year old woman presented with a 1.5 year history of oral ulceration. There were no lesions on the skin or other mucosal sites. Histology and immunostaining were consistent with pemphigus vulgaris. Control of oral ulceration and normal oral function were achieved after systemic corticosteroids and immunosuppressive agents were instituted.

Keyword

Pemphigus vulgaris; Oral mucosa

MeSH Terms

Adrenal Cortex Hormones
Autoantibodies
Blister
Cell Separation
Epithelium
Extracellular Space
Female
Humans
Immunosuppressive Agents
Keratinocytes
Mouth Mucosa
Oral Ulcer
Pemphigus
Plasminogen
Skin
Adrenal Cortex Hormones
Autoantibodies
Immunosuppressive Agents
Plasminogen
Full Text Links
  • JKAMPRS
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr